首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Intraluminal bypass devices as an alternative to defunctioning stoma in anterior resection: A systematic review of safety and feasibility 腔内旁路装置作为前切除术中功能性造口的替代方法:安全性和可行性的系统综述。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-15 DOI: 10.1111/codi.70408
Peiyu Li, Tinghan Yang, Xuewen Xu, Ziqiang Wang

Aim

To systematically evaluate the safety and feasibility of intraluminal bypass devices (IBDs) as alternatives to defunctioning stoma for colorectal/coloanal anastomoses after anterior resection.

Method

The present systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Endpoints were feasibility (placement, fixation, maintenance, removal) and safety (device-related events, postoperative morbidity and anastomotic leakage).

Results

In total, 10 studies evaluating five types of IBDs were included in this systematic review. Each IBD had a head portion with a proximal fixation component and a tail portion consisting of a transanal endoluminal tubular sheath or tube for faecal diversion but with a distinct design. Device-related events included migration, sheath internalization, partial colonic wall erosions and enterocutaneous fistula. Overall postoperative complications were reported in 0–74% and anastomotic leakage in 0–32% across studies. Stoma avoidance ranged from 66.7% to 100%.

Conclusion

IBDs are technically feasible and appear acceptably safe, with potential to reduce reliance on defunctioning stoma; however, evidence remains early and heterogeneous. Further studies are needed, and optimization of fixation and anti-migration strategies should be prioritized.

目的:系统评价腔内旁路装置(IBDs)作为结肠/结肠吻合器前切除术后功能性造口的替代方案的安全性和可行性。方法:本系统评价按照系统评价和荟萃分析首选报告项目(PRISMA)指南进行。终点是可行性(放置、固定、维持、移除)和安全性(器械相关事件、术后发病率和吻合口漏)。结果:本系统综述共纳入5种ibd类型的10项研究。每个IBD的头部部分有近端固定组件,尾部部分由经肛门腔内管鞘或用于粪便转移的管组成,但设计独特。器械相关事件包括迁移、鞘内化、部分结肠壁糜烂和肠皮瘘。所有研究报告的总体术后并发症发生率为0-74%,吻合口瘘发生率为0-32%。避免造口的范围从66.7%到100%。结论:ibd在技术上是可行的,并且表现出可接受的安全性,有可能减少对功能性造口的依赖;然而,证据仍然很早期,而且种类繁多。需要进一步研究,优化固定和防迁移策略。
{"title":"Intraluminal bypass devices as an alternative to defunctioning stoma in anterior resection: A systematic review of safety and feasibility","authors":"Peiyu Li,&nbsp;Tinghan Yang,&nbsp;Xuewen Xu,&nbsp;Ziqiang Wang","doi":"10.1111/codi.70408","DOIUrl":"10.1111/codi.70408","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To systematically evaluate the safety and feasibility of intraluminal bypass devices (IBDs) as alternatives to defunctioning stoma for colorectal/coloanal anastomoses after anterior resection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>The present systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Endpoints were feasibility (placement, fixation, maintenance, removal) and safety (device-related events, postoperative morbidity and anastomotic leakage).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, 10 studies evaluating five types of IBDs were included in this systematic review. Each IBD had a head portion with a proximal fixation component and a tail portion consisting of a transanal endoluminal tubular sheath or tube for faecal diversion but with a distinct design. Device-related events included migration, sheath internalization, partial colonic wall erosions and enterocutaneous fistula. Overall postoperative complications were reported in 0–74% and anastomotic leakage in 0–32% across studies. Stoma avoidance ranged from 66.7% to 100%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>IBDs are technically feasible and appear acceptably safe, with potential to reduce reliance on defunctioning stoma; however, evidence remains early and heterogeneous. Further studies are needed, and optimization of fixation and anti-migration strategies should be prioritized.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146200389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical use of a 3D head-mounted display in hybrid robotic and transperineal rectal surgery 3D头戴式显示器在混合机器人和经会阴直肠手术中的实际应用。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-15 DOI: 10.1111/codi.70406
Tomoaki Okada, Akinari Nomura, Kenta Horita, Susumu Inamoto, Yoshiharu Sakai

Background

With the widespread adoption of robotic surgical platforms, a hybrid approach for rectal cancer combining abdominal robotic surgery with transanal or transperineal total mesorectal excision (TME) technique has been introduced. However, in this two-team approach, the docked robotic arms extend over the patient and frequently obstruct the transanal surgeon's line of sight, making it difficult to view the operative monitor and causing excessive cervical rotation and neck strain. To address this ergonomic issue, we implemented a three-dimensional head-mounted display (3D-HMD) using 3D View Vision system (FA. System Engineering Co., Ehime, Japan), which provides stereoscopic, high-definition visualization regardless of head position.

Materials and Methods

The system offers 3840 × 1080-pixel resolution, minimal latency, light weight, and seamless switching between robotic and transperineal views, and images from both 2D and 3D endoscopes can be converted to stereoscopic 3D. The transperineal surgeon wore the 3D-HMD during transperineal TME and lateral pelvic lymph node dissection in coordination with the abdominal robotic team. Using this set-up, five abdominoperineal resections and one total pelvic exenteration were performed, all with bilateral lateral pelvic lymph node dissection.

Results

The median operating time was 530 min, with a median 3D-HMD usage of 315 min. The surgeon subjectively reported no cervical discomfort, visual disturbance, or device-related fatigue, and the visual field remained stable throughout the prolonged procedures.

Conclusion

The integration of a 3D-HMD into a hybrid two-team approach was feasible and subjectively well tolerated, providing high-resolution stereoscopic visualization without reported cervical discomfort.

背景:随着机器人手术平台的广泛采用,一种将腹部机器人手术与经肛门或经会阴全肠系膜切除(TME)技术相结合的直肠癌混合入路已经被引入。然而,在这种两组方法中,对接的机械臂延伸到患者身上,经常阻碍经肛门外科医生的视线,使其难以看到手术监护仪,并造成过度的颈椎旋转和颈部劳伤。为了解决这个人体工程学问题,我们使用3D视觉系统(FA)实现了一个三维头戴式显示器(3D- hmd)。系统工程公司,爱母,日本),它提供立体,高清晰度的可视化,无论头部位置。材料和方法:该系统提供3840 × 1080像素的分辨率,最小延迟,重量轻,在机器人和经会阴视图之间无缝切换,2D和3D内窥镜的图像都可以转换为立体3D。经会阴外科医生佩戴3D-HMD进行经会阴TME和骨盆外侧淋巴结清扫,与腹部机器人团队协调。使用这种装置,进行了5次腹部会阴切除和1次全盆腔切除,所有手术均伴有双侧盆腔淋巴结清扫。结果:手术时间中位数为530 min, 3D-HMD使用时间中位数为315 min。外科医生主观上报告没有颈椎不适、视力障碍或器械相关疲劳,并且在整个延长的手术过程中视野保持稳定。结论:将3D-HMD整合到混合两组方法中是可行的,主观上耐受良好,提供高分辨率立体可视化,无颈椎不适报告。
{"title":"Practical use of a 3D head-mounted display in hybrid robotic and transperineal rectal surgery","authors":"Tomoaki Okada,&nbsp;Akinari Nomura,&nbsp;Kenta Horita,&nbsp;Susumu Inamoto,&nbsp;Yoshiharu Sakai","doi":"10.1111/codi.70406","DOIUrl":"10.1111/codi.70406","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>With the widespread adoption of robotic surgical platforms, a hybrid approach for rectal cancer combining abdominal robotic surgery with transanal or transperineal total mesorectal excision (TME) technique has been introduced. However, in this two-team approach, the docked robotic arms extend over the patient and frequently obstruct the transanal surgeon's line of sight, making it difficult to view the operative monitor and causing excessive cervical rotation and neck strain. To address this ergonomic issue, we implemented a three-dimensional head-mounted display (3D-HMD) using 3D View Vision system (FA. System Engineering Co., Ehime, Japan), which provides stereoscopic, high-definition visualization regardless of head position.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>The system offers 3840 × 1080-pixel resolution, minimal latency, light weight, and seamless switching between robotic and transperineal views, and images from both 2D and 3D endoscopes can be converted to stereoscopic 3D. The transperineal surgeon wore the 3D-HMD during transperineal TME and lateral pelvic lymph node dissection in coordination with the abdominal robotic team. Using this set-up, five abdominoperineal resections and one total pelvic exenteration were performed, all with bilateral lateral pelvic lymph node dissection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The median operating time was 530 min, with a median 3D-HMD usage of 315 min. The surgeon subjectively reported no cervical discomfort, visual disturbance, or device-related fatigue, and the visual field remained stable throughout the prolonged procedures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The integration of a 3D-HMD into a hybrid two-team approach was feasible and subjectively well tolerated, providing high-resolution stereoscopic visualization without reported cervical discomfort.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146200332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing treatment strategies for early-onset mucinous adenocarcinoma of the colon: A SEER database analysis 优化早发性结肠粘液腺癌的治疗策略:SEER数据库分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-14 DOI: 10.1111/codi.70390
Cameron Perrone, Sameh Hany Emile, Christopher Lopez, Spencer Barnes, Anjelli Wignakumar, Matthew Bilotti, Steven D. Wexner

Background

Colorectal mucinous adenocarcinoma (MAC) is challenging due to its unique pathophysiology and increasing incidence in younger populations. Treatment guidelines for early-onset MAC remain unclear, with clinical decisions often based on extrapolated data from classical adenocarcinoma. We aimed to assess the association between the extent of surgical resection and systemic therapy in patients with early-onset colonic MAC and survival.

Methods

Retrospective cohort analysis of patients aged 20–50 with stage II–III colonic MAC using the SEER database (2000–2020). We evaluated overall survival (OS) and cancer-specific survival (CSS) based on surgical resection (segmental vs. extended) and systemic therapy, using Kaplan–Meier and Cox regression analyses.

Results

The cohort included 2553 patients (58.5% male; mean age 42.7 years). Segmental resection was performed in 27.6%. Extended resection was more commonly performed in right-sided and stage III disease. Systemic therapy was administered to 62.1%, predominantly for stage III disease with unfavourable tumour features. Systemic therapy was associated with improved restricted mean 5-year CSS (51.7 vs. 47.8 months, p = 0.041) and OS (51.1 vs. 45.9 months, p = 0.008) in stage III, but not stage II, disease. Extended resection was associated with a modest survival benefit for CSS (56.5 vs. 54.3 months, p = 0.027) and OS (56.0 vs. 53.3 months, p = 0.007) in stage II, but not stage III, disease.

Conclusion

Systemic therapy was associated with a significant survival benefit in patients with stage III early-onset MAC, supporting its role as a cornerstone of treatment despite the histology's presumed chemoresistance.

背景:结直肠粘液腺癌(MAC)由于其独特的病理生理和在年轻人群中发病率的增加而具有挑战性。早发性MAC的治疗指南尚不明确,临床决策通常基于经典腺癌的推断数据。我们的目的是评估早发性结肠MAC患者的手术切除程度和全身治疗与生存之间的关系。方法:使用SEER数据库(2000-2020)对20-50岁II-III期结肠MAC患者进行回顾性队列分析。我们使用Kaplan-Meier和Cox回归分析,评估了基于手术切除(节段性与扩展性)和全身治疗的总生存期(OS)和癌症特异性生存期(CSS)。结果:该队列包括2553例患者(58.5%为男性,平均年龄42.7岁)。节段性切除占27.6%。延长切除更常见于右侧和III期疾病。62.1%的患者接受了全身治疗,主要用于具有不利肿瘤特征的III期疾病。在III期疾病中,全身治疗与限制性平均5年CSS(51.7个月vs 47.8个月,p = 0.041)和OS(51.1个月vs 45.9个月,p = 0.008)改善相关,但与II期疾病无关。延长切除与II期疾病的CSS(56.5个月vs 54.3个月,p = 0.027)和OS(56.0个月vs 53.3个月,p = 0.007)的生存获益相关,但与III期疾病无关。结论:在III期早发性MAC患者中,全身治疗与显著的生存获益相关,支持其作为治疗基石的作用,尽管组织学上假定有化疗耐药。
{"title":"Optimizing treatment strategies for early-onset mucinous adenocarcinoma of the colon: A SEER database analysis","authors":"Cameron Perrone,&nbsp;Sameh Hany Emile,&nbsp;Christopher Lopez,&nbsp;Spencer Barnes,&nbsp;Anjelli Wignakumar,&nbsp;Matthew Bilotti,&nbsp;Steven D. Wexner","doi":"10.1111/codi.70390","DOIUrl":"10.1111/codi.70390","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Colorectal mucinous adenocarcinoma (MAC) is challenging due to its unique pathophysiology and increasing incidence in younger populations. Treatment guidelines for early-onset MAC remain unclear, with clinical decisions often based on extrapolated data from classical adenocarcinoma. We aimed to assess the association between the extent of surgical resection and systemic therapy in patients with early-onset colonic MAC and survival.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Retrospective cohort analysis of patients aged 20–50 with stage II–III colonic MAC using the SEER database (2000–2020). We evaluated overall survival (OS) and cancer-specific survival (CSS) based on surgical resection (segmental vs. extended) and systemic therapy, using Kaplan–Meier and Cox regression analyses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The cohort included 2553 patients (58.5% male; mean age 42.7 years). Segmental resection was performed in 27.6%. Extended resection was more commonly performed in right-sided and stage III disease. Systemic therapy was administered to 62.1%, predominantly for stage III disease with unfavourable tumour features. Systemic therapy was associated with improved restricted mean 5-year CSS (51.7 vs. 47.8 months, <i>p</i> = 0.041) and OS (51.1 vs. 45.9 months, <i>p</i> = 0.008) in stage III, but not stage II, disease. Extended resection was associated with a modest survival benefit for CSS (56.5 vs. 54.3 months, <i>p</i> = 0.027) and OS (56.0 vs. 53.3 months, <i>p</i> = 0.007) in stage II, but not stage III, disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Systemic therapy was associated with a significant survival benefit in patients with stage III early-onset MAC, supporting its role as a cornerstone of treatment despite the histology's presumed chemoresistance.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of wound protectors in reducing surgical site infections in patients undergoing open colorectal surgery: A systematic review and meta-analysis 创面保护器减少结直肠开腹手术患者手术部位感染的疗效:系统回顾和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-14 DOI: 10.1111/codi.70401
Arusha Desai, Rahul Bisht, Sidharth Misra, Mangesh Kritya, Anjali Bhardwaj, Soubhik Chakraborty, Tejaswini Pisipati

Background

The incidence of surgical site infections (SSIs) has been reported to be significantly higher in colorectal surgeries compared to other surgical procedures. Wound protectors have been developed to help reduce the incidence of SSIs by creating a barrier between the incisional wound and the contaminated surgical field, but their efficacy remains uncertain.

Objective

To assess whether the use of wound protectors reduces the incidence of SSIs in patients undergoing open colorectal surgery.

Data Sources

A comprehensive literature review was conducted using PubMed, Embase, Web of Science and Cochrane databases from inception to January 2025.

Study Selection

Randomised controlled trials (RCTs) assessing the efficacy of wound protectors for reducing the incidence of SSIs in patients undergoing open colorectal surgery.

Interventions

The intervention consisted of wound protectors (e.g., Alexis O-ring wound retractors, plastic ring drape).

Main Outcomes Measures

The main outcome was SSI. We pooled risk ratios (RRs) with a 95% confidence interval (CI) using a random effects model. Statistical analysis was performed using R software (version 4.4.2).

Results

We included 6 RCTs comprising 666 patients, of whom 327 (49 %) were randomised to the wound protectors’ group. The mean follow-up duration was 30 days post-operatively. The incidence of SSIs was significantly lower in the intervention group (RR 0.44; 95% CI 0.22–0.88; p = 0.021). Subgroup analysis of four RCTs evaluating Alexis-O ring wound retractors showed a significantly lower incidence of SSIs in the experimental group (RR 0.21; 95% CI 0.09–0.48; p < 0.001).

Conclusion

Wound protectors were associated with a significantly lower incidence of SSIs in patients undergoing open colorectal surgery.

背景:据报道,与其他外科手术相比,结直肠手术手术部位感染(ssi)的发生率明显更高。伤口保护器通过在切口伤口和受污染的手术野之间建立屏障来帮助减少ssi的发生率,但其效果仍不确定。目的:评价创面保护器的使用是否能降低结直肠开腹手术患者ssi的发生率。数据来源:对PubMed、Embase、Web of Science和Cochrane数据库从成立到2025年1月进行了全面的文献综述。研究选择:随机对照试验(RCTs)评估伤口保护器降低开放性结直肠手术患者ssi发生率的疗效。干预措施:干预措施包括伤口保护装置(如Alexis o型环伤口牵开器、塑料环垂布)。主要结局指标:主要结局指标为SSI。我们使用随机效应模型将风险比(rr)与95%置信区间(CI)合并。采用R软件(4.4.2版)进行统计分析。结果:我们纳入了6项随机对照试验,包括666例患者,其中327例(49%)随机分配到伤口保护器组。术后平均随访时间30天。干预组ssi发生率明显低于对照组(RR 0.44; 95% CI 0.22-0.88; p = 0.021)。四项评估Alexis-O环形伤口牵开器的随机对照试验的亚组分析显示,实验组的ssi发生率显著降低(RR 0.21; 95% CI 0.09-0.48; p)。结论:伤口保护器与结肠直肠开腹手术患者ssi发生率显著降低相关。
{"title":"Efficacy of wound protectors in reducing surgical site infections in patients undergoing open colorectal surgery: A systematic review and meta-analysis","authors":"Arusha Desai,&nbsp;Rahul Bisht,&nbsp;Sidharth Misra,&nbsp;Mangesh Kritya,&nbsp;Anjali Bhardwaj,&nbsp;Soubhik Chakraborty,&nbsp;Tejaswini Pisipati","doi":"10.1111/codi.70401","DOIUrl":"10.1111/codi.70401","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The incidence of surgical site infections (SSIs) has been reported to be significantly higher in colorectal surgeries compared to other surgical procedures. Wound protectors have been developed to help reduce the incidence of SSIs by creating a barrier between the incisional wound and the contaminated surgical field, but their efficacy remains uncertain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To assess whether the use of wound protectors reduces the incidence of SSIs in patients undergoing open colorectal surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources</h3>\u0000 \u0000 <p>A comprehensive literature review was conducted using PubMed, Embase, Web of Science and Cochrane databases from inception to January 2025.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Selection</h3>\u0000 \u0000 <p>Randomised controlled trials (RCTs) assessing the efficacy of wound protectors for reducing the incidence of SSIs in patients undergoing open colorectal surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>The intervention consisted of wound protectors (e.g., Alexis O-ring wound retractors, plastic ring drape).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcomes Measures</h3>\u0000 \u0000 <p>The main outcome was SSI. We pooled risk ratios (RRs) with a 95% confidence interval (CI) using a random effects model. Statistical analysis was performed using R software (version 4.4.2).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We included 6 RCTs comprising 666 patients, of whom 327 (49 %) were randomised to the wound protectors’ group. The mean follow-up duration was 30 days post-operatively. The incidence of SSIs was significantly lower in the intervention group (RR 0.44; 95% CI 0.22–0.88; <i>p</i> = 0.021). Subgroup analysis of four RCTs evaluating Alexis-O ring wound retractors showed a significantly lower incidence of SSIs in the experimental group (RR 0.21; 95% CI 0.09–0.48; <i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Wound protectors were associated with a significantly lower incidence of SSIs in patients undergoing open colorectal surgery.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing various bowel preparation regimens in constipated patients undergoing colonoscopy: A systematic review and network meta-analysis of randomised controlled trials 比较便秘患者接受结肠镜检查的各种肠道准备方案:随机对照试验的系统回顾和网络荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-13 DOI: 10.1111/codi.70399
Zain ul Abideen, Muhammad Hassan Waseem, Areeba Shoaib, Noor-ul-Huda Ramzan, Muhammad Tayyab Amer Ch, Pawan Kumar Thada, Prasun Kumar Jalal

Background

Colonoscopy effectiveness in detecting colorectal carcinoma depends on adequate bowel preparation (ABP). This network meta-analysis assesses the efficacy and safety of various bowel preparation regimens in patients with constipation.

Methods

PubMed, Cochrane Central and ScienceDirect were searched till April 2025. A frequentist network meta-analysis was performed using the ‘meta’ and ‘netmeta’ packages on R version 4.3.3. The ranking was done using P-scores.

Results

Fifteen randomised controlled trials were included. Compared with 4 L polyethylene glycol (PEG), 3 L PEG + 3d-linaclotide (Lin) (risk ratio [RR] = 1.29; 95% confidence intervals [CI]: [1.12, 1.47]), 4 L PEG + 1d-Lin (RR = 1.25; 95% CI: [1.04, 1.51]), sodium phosphate (NaP) + bisacodyl (RR = 1.52; 95% CI: [1.09, 2.10]), probiotic 14d + NaP (RR = 3.59; 95% CI: [1.83, 7.04]) may show improvements in the rate of ABP. The probiotic 14d + NaP regimen was ranked best regarding ABP (P-score = 0.99) and bloating (P-score = 0.84). The 3 L PEG + 3d-Lin showed a reduction (RR = 0.18; 95% CI: [0.04, 0.88]) in abdominal pain and was ranked best regarding abdominal pain (P-score = 0.89) and vomiting (P-score = 0.80). The 4 L PEG + 1d-Lin was ranked best (P-score = 0.77) in terms of nausea.

Conclusion

The 14d-probiotics + NaP and 3 L PEG + 3d-Lin may be among the more effective and tolerable bowel preparation regimens. While adverse events were similar, the observed reduction in abdominal pain with 3 L PEG + 3d-Lin may suggest improved patient comfort and adherence.

背景:结肠镜检查检测结直肠癌的有效性取决于充分的肠准备(ABP)。本网络荟萃分析评估了便秘患者各种肠道准备方案的有效性和安全性。方法:检索PubMed、Cochrane Central和ScienceDirect至2025年4月。使用R版本4.3.3上的“meta”和“netmeta”包进行频率网络元分析。排名是用p分数来完成的。结果:纳入15项随机对照试验。与4 L聚乙二醇(PEG), 3 L挂钩+ 3 d-linaclotide(林)(风险率(RR) = 1.29; 95%可信区间[CI]: [1.12, 1.47]), 4 L挂钩+ 1 d-lin (RR = 1.25; 95%置信区间:[1.04,1.51]),磷酸钠(午睡)+ bisacodyl (RR = 1.52; 95%置信区间:[1.09,2.10]),益生菌14 d +小睡(RR = 3.59; 95%置信区间:[1.83,7.04])可能显示改善ABP。益生菌14 d +小睡方案排名最好的关于ABP (P-score = 0.99)和肿胀(P-score = 0.84)。3l PEG + 3d-Lin显示腹痛减轻(RR = 0.18; 95% CI:[0.04, 0.88]),在腹痛(P-score = 0.89)和呕吐(P-score = 0.80)方面排名最佳。4 L PEG + 1d-Lin在恶心方面排名最佳(P-score = 0.77)。结论:14d益生菌+ NaP和3l PEG + 3d-Lin可能是更有效和可耐受的肠道准备方案。虽然不良事件相似,但3l PEG + 3d-Lin观察到的腹痛减少可能表明患者舒适度和依从性得到改善。
{"title":"Comparing various bowel preparation regimens in constipated patients undergoing colonoscopy: A systematic review and network meta-analysis of randomised controlled trials","authors":"Zain ul Abideen,&nbsp;Muhammad Hassan Waseem,&nbsp;Areeba Shoaib,&nbsp;Noor-ul-Huda Ramzan,&nbsp;Muhammad Tayyab Amer Ch,&nbsp;Pawan Kumar Thada,&nbsp;Prasun Kumar Jalal","doi":"10.1111/codi.70399","DOIUrl":"10.1111/codi.70399","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Colonoscopy effectiveness in detecting colorectal carcinoma depends on adequate bowel preparation (ABP). This network meta-analysis assesses the efficacy and safety of various bowel preparation regimens in patients with constipation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>PubMed, Cochrane Central and ScienceDirect were searched till April 2025. A frequentist network meta-analysis was performed using the ‘meta’ and ‘netmeta’ packages on R version 4.3.3. The ranking was done using P-scores.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifteen randomised controlled trials were included. Compared with 4 L polyethylene glycol (PEG), 3 L PEG + 3d-linaclotide (Lin) (risk ratio [RR] = 1.29; 95% confidence intervals [CI]: [1.12, 1.47]), 4 L PEG + 1d-Lin (RR = 1.25; 95% CI: [1.04, 1.51]), sodium phosphate (NaP) + bisacodyl (RR = 1.52; 95% CI: [1.09, 2.10]), probiotic 14d + NaP (RR = 3.59; 95% CI: [1.83, 7.04]) may show improvements in the rate of ABP. The probiotic 14d + NaP regimen was ranked best regarding ABP (P-score = 0.99) and bloating (P-score = 0.84). The 3 L PEG + 3d-Lin showed a reduction (RR = 0.18; 95% CI: [0.04, 0.88]) in abdominal pain and was ranked best regarding abdominal pain (P-score = 0.89) and vomiting (P-score = 0.80). The 4 L PEG + 1d-Lin was ranked best (P-score = 0.77) in terms of nausea.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The 14d-probiotics + NaP and 3 L PEG + 3d-Lin may be among the more effective and tolerable bowel preparation regimens. While adverse events were similar, the observed reduction in abdominal pain with 3 L PEG + 3d-Lin may suggest improved patient comfort and adherence.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146178182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An international cohort study of wound closure and surgical site infection prevention strategies in abdominal surgery (WOLVERINE): Protocol for a multicenter international study 一项关于腹部手术伤口闭合和手术部位感染预防策略的国际队列研究(WOLVERINE):一项多中心国际研究方案
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-13 DOI: 10.1111/codi.70364
European Society of Coloproctology (ESCP) WOLVERINE Collaborating Group

Background

The European Society of Coloproctology (ESCP) conducted a global survey capturing wound closure practices across a spectrum of surgical contexts, including clean-contaminated and contaminated operations. The results revealed considerable variations in fascial closure techniques, suture types, and infection prevention measures, even within comparable operative scenarios. This variability highlights the urgent need for high-quality, real-world data to inform the development of evidence-based, globally relevant best practices in abdominal surgery.

Method

The WOLVERINE study is an international, prospective, multicenter cohort study designed to evaluate current wound closure techniques and surgical site infection (SSI) prevention strategies in adult patients undergoing general or colorectal abdominal surgery. The primary objective of this study is to investigate the relationship between wound closure materials and techniques and the development of early and late wound complications. Further objectives include quantifying the burden of wound complications on patient-reported outcomes, health-related quality of life, healthcare utilisation, and postoperative recovery timelines.

Participating centres include any hospital or surgical unit performing elective, expedited, or emergency abdominal, general, and colorectal operations via open, laparoscopic, or robotic approaches. This study adheres to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for reporting cohort studies.

Discussion

The WOLVERINE cohort study will provide the first truly global, prospective portrait of abdominal wall closure practice and its short- and long-term sequelae across the full spectrum of elective, expedited, and emergency general and colorectal surgery. This project bridges this fundamental knowledge gap.

欧洲肛肠学会(ESCP)进行了一项全球调查,收集了一系列外科手术环境下的伤口闭合实践,包括清洁污染和污染手术。结果显示,即使在类似的手术情况下,筋膜闭合技术、缝合类型和感染预防措施也存在相当大的差异。这种可变性凸显了迫切需要高质量、真实的数据,以便为以证据为基础、全球相关的腹部外科最佳实践的发展提供信息。方法WOLVERINE研究是一项国际、前瞻性、多中心队列研究,旨在评估接受普通或结直肠腹部手术的成年患者目前的伤口关闭技术和手术部位感染(SSI)预防策略。本研究的主要目的是探讨伤口闭合材料和技术与早期和晚期伤口并发症的关系。进一步的目标包括量化伤口并发症对患者报告结果、健康相关生活质量、医疗保健利用和术后恢复时间表的负担。参与中心包括通过开放、腹腔镜或机器人方法进行选择性、快速或紧急腹部、一般和结肠直肠手术的任何医院或外科单位。本研究遵循STROBE(加强流行病学观察性研究报告)队列研究报告指南。WOLVERINE队列研究将提供第一个真正全球性的、前瞻性的腹壁闭合实践及其短期和长期后遗症,涵盖所有选择性、加速和紧急普通和结直肠手术。该项目弥补了这一基本知识差距。
{"title":"An international cohort study of wound closure and surgical site infection prevention strategies in abdominal surgery (WOLVERINE): Protocol for a multicenter international study","authors":"European Society of Coloproctology (ESCP) WOLVERINE Collaborating Group","doi":"10.1111/codi.70364","DOIUrl":"10.1111/codi.70364","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The European Society of Coloproctology (ESCP) conducted a global survey capturing wound closure practices across a spectrum of surgical contexts, including clean-contaminated and contaminated operations. The results revealed considerable variations in fascial closure techniques, suture types, and infection prevention measures, even within comparable operative scenarios. This variability highlights the urgent need for high-quality, real-world data to inform the development of evidence-based, globally relevant best practices in abdominal surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>The WOLVERINE study is an international, prospective, multicenter cohort study designed to evaluate current wound closure techniques and surgical site infection (SSI) prevention strategies in adult patients undergoing general or colorectal abdominal surgery. The primary objective of this study is to investigate the relationship between wound closure materials and techniques and the development of early and late wound complications. Further objectives include quantifying the burden of wound complications on patient-reported outcomes, health-related quality of life, healthcare utilisation, and postoperative recovery timelines.</p>\u0000 \u0000 <p>Participating centres include any hospital or surgical unit performing elective, expedited, or emergency abdominal, general, and colorectal operations via open, laparoscopic, or robotic approaches. This study adheres to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for reporting cohort studies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>The WOLVERINE cohort study will provide the first truly global, prospective portrait of abdominal wall closure practice and its short- and long-term sequelae across the full spectrum of elective, expedited, and emergency general and colorectal surgery. This project bridges this fundamental knowledge gap.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70364","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146256460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
British Society of Gastroenterology and Association of Coloproctology of Great Britain and Ireland position on tranexamic acid in upper and lower gastrointestinal bleeding 英国胃肠病学协会和英国及爱尔兰结肠直肠病学协会对氨甲环酸在上、下消化道出血中的作用的立场。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-11 DOI: 10.1111/codi.70404
Nigel Trudgill, Katie Yeadon, Matthew Kurien, the British Society of Gastroenterology and the Association of Coloproctology of Great Britain and Ireland
<p>Following a concern raised to NHS England's National Patient Safety Team regarding tranexamic acid use in gastrointestinal bleeding, and in light of the 2020 publication of the HALT-IT trial results, we are providing this position statement. Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits the breakdown of fibrin clots by blocking plasminogen activation. Its efficacy in reducing bleeding and mortality has been demonstrated in trauma patients (CRASH-2) and in reducing bleeding in surgical patients [<span>1, 2</span>]. Systematic review of small older randomized trials in upper GI bleeding suggested that TXA might reduce mortality [<span>3</span>]. However, these trials had methodological weaknesses and were conducted before routine use of modern therapies (such as proton-pump inhibitors and endoscopic haemostasis) [<span>4</span>]. The 2018 BSG guidelines on acute lower gastrointestinal bleeding recommended TXA use was confined to clinical trials, pending the HALT-IT trial results [<span>5</span>].</p><p>The HALT-IT trial was a large, international, double-blind, placebo-controlled randomized controlled trial (<i>n</i> = 12,009) comparing intra-venous TXA versus placebo in patients with significant upper or lower GI bleeding [<span>6</span>]. There was no statistically significant reduction in the primary outcome of death due to bleeding within 5 days (3.7% in TXA arm vs. 3.8% in placebo; risk ratio 0.99, 95% CI 0.82–1.18). The trial observed an increased risk of venous thromboembolism (0.8% in TXA group vs. 0.4% in placebo; RR ~1.85, 95% CI 1.15–2.98) and seizures (0.6% vs. 0.4%; RR ~1.73, 95% CI 1.03–2.93).</p><p>HALT-IT was a high-quality trial that avoided the methodological weaknesses of previous trials of TXA in GI bleeding, whose results are likely to be explained by bias.</p><p>Based on the evidence from the HALT-IT study, TXA should not be routinely used in acute upper or lower GI bleeding, given its lack of mortality benefit and safety concerns. Outside of a research context, if clinicians consider TXA use in truly exceptional circumstances where all conventional therapies have been exhausted, this must be a consultant gastroenterologist/gastrointestinal surgeon decision made with the patient and clearly documented as a use without established evidence of benefit. Use of TXA in acute GI bleeding in NHS hospitals should be reported and monitored within local governance frameworks, to ensure compliance with this position.</p><p>On behalf of the British Society of Gastroenterology and the Association of Coloproctology of Great Britain and Ireland.</p><p>Prof. Nigel Trudgill</p><p>Miss Katie Yeadon</p><p>Dr. Matthew Kurien</p><p><b>Nigel Trudgill:</b> Conceptualization; writing – original draft. <b>Katie Yeadon:</b> Writing – review and editing. <b>Matthew Kurien:</b> Writing – review and editing.</p><p>Not applicable.</p><p>Prof. Nigel Trudgill is a BSG Elected Councillor; Miss Katie Yeadon is the Chair of the ACPGBI Colo
在向NHS英格兰国家患者安全团队提出关于氨甲环酸在胃肠道出血中的使用的担忧之后,鉴于2020年发布的HALT-IT试验结果,我们提供此立场声明。氨甲环酸(TXA)是一种抗纤溶剂,通过阻断纤溶酶原的激活来抑制纤维蛋白凝块的分解。在创伤患者(CRASH-2)和外科患者中,其减少出血和死亡率的功效已得到证实[1,2]。对上消化道出血的早期小型随机试验的系统回顾表明,TXA可能会降低死亡率。然而,这些试验在方法学上存在缺陷,而且是在常规使用现代疗法(如质子泵抑制剂和内镜止血)之前进行的。2018年关于急性下消化道出血的BSG指南推荐使用TXA仅限于临床试验,等待HALT-IT试验结果。HALT-IT试验是一项大型、国际、双盲、安慰剂对照的随机对照试验(n = 12,009),比较静脉内注射TXA与安慰剂在显著上消化道或下消化道出血患者中的疗效。5天内出血死亡的主要结局无统计学显著降低(TXA组3.7% vs安慰剂组3.8%;风险比0.99,95% CI 0.82-1.18)。该试验观察到静脉血栓栓塞的风险增加(TXA组为0.8%,安慰剂组为0.4%;RR ~1.85, 95% CI 1.15-2.98)和癫痫发作(0.6%对0.4%;RR ~1.73, 95% CI 1.03-2.93)。HALT-IT是一项高质量的试验,它避免了先前TXA在胃肠道出血试验中方法上的弱点,这些试验的结果可能是由偏倚解释的。基于HALT-IT研究的证据,鉴于其缺乏死亡率益处和安全性问题,TXA不应常规用于急性上消化道或下消化道出血。在研究背景之外,如果临床医生考虑在所有常规疗法都已用尽的特殊情况下使用TXA,这必须是胃肠病学顾问/胃肠外科医生与患者共同做出的决定,并明确记录为没有确定的益处证据的使用。在NHS医院急性消化道出血中使用TXA应在地方治理框架内报告和监测,以确保遵守这一立场。我谨代表英国胃肠病学会和大不列颠及爱尔兰直肠病协会。奈杰尔·特鲁吉小姐凯蒂·耶顿博士。Matthew KurienNigel Trudgill:概念化;写作-原稿。Katie Yeadon:写作——评论和编辑。马修·库里恩:写作-评论和编辑。不是applicable.Prof。Nigel Trudgill是BSG当选议员;Katie Yeadon小姐是ACPGBI结肠镜小组委员会主席;Matthew Kurien博士是BSG临床服务委员会主席。作者没有什么可报告的。不适用。
{"title":"British Society of Gastroenterology and Association of Coloproctology of Great Britain and Ireland position on tranexamic acid in upper and lower gastrointestinal bleeding","authors":"Nigel Trudgill,&nbsp;Katie Yeadon,&nbsp;Matthew Kurien,&nbsp;the British Society of Gastroenterology and the Association of Coloproctology of Great Britain and Ireland","doi":"10.1111/codi.70404","DOIUrl":"10.1111/codi.70404","url":null,"abstract":"&lt;p&gt;Following a concern raised to NHS England's National Patient Safety Team regarding tranexamic acid use in gastrointestinal bleeding, and in light of the 2020 publication of the HALT-IT trial results, we are providing this position statement. Tranexamic acid (TXA) is an antifibrinolytic agent that inhibits the breakdown of fibrin clots by blocking plasminogen activation. Its efficacy in reducing bleeding and mortality has been demonstrated in trauma patients (CRASH-2) and in reducing bleeding in surgical patients [&lt;span&gt;1, 2&lt;/span&gt;]. Systematic review of small older randomized trials in upper GI bleeding suggested that TXA might reduce mortality [&lt;span&gt;3&lt;/span&gt;]. However, these trials had methodological weaknesses and were conducted before routine use of modern therapies (such as proton-pump inhibitors and endoscopic haemostasis) [&lt;span&gt;4&lt;/span&gt;]. The 2018 BSG guidelines on acute lower gastrointestinal bleeding recommended TXA use was confined to clinical trials, pending the HALT-IT trial results [&lt;span&gt;5&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;The HALT-IT trial was a large, international, double-blind, placebo-controlled randomized controlled trial (&lt;i&gt;n&lt;/i&gt; = 12,009) comparing intra-venous TXA versus placebo in patients with significant upper or lower GI bleeding [&lt;span&gt;6&lt;/span&gt;]. There was no statistically significant reduction in the primary outcome of death due to bleeding within 5 days (3.7% in TXA arm vs. 3.8% in placebo; risk ratio 0.99, 95% CI 0.82–1.18). The trial observed an increased risk of venous thromboembolism (0.8% in TXA group vs. 0.4% in placebo; RR ~1.85, 95% CI 1.15–2.98) and seizures (0.6% vs. 0.4%; RR ~1.73, 95% CI 1.03–2.93).&lt;/p&gt;&lt;p&gt;HALT-IT was a high-quality trial that avoided the methodological weaknesses of previous trials of TXA in GI bleeding, whose results are likely to be explained by bias.&lt;/p&gt;&lt;p&gt;Based on the evidence from the HALT-IT study, TXA should not be routinely used in acute upper or lower GI bleeding, given its lack of mortality benefit and safety concerns. Outside of a research context, if clinicians consider TXA use in truly exceptional circumstances where all conventional therapies have been exhausted, this must be a consultant gastroenterologist/gastrointestinal surgeon decision made with the patient and clearly documented as a use without established evidence of benefit. Use of TXA in acute GI bleeding in NHS hospitals should be reported and monitored within local governance frameworks, to ensure compliance with this position.&lt;/p&gt;&lt;p&gt;On behalf of the British Society of Gastroenterology and the Association of Coloproctology of Great Britain and Ireland.&lt;/p&gt;&lt;p&gt;Prof. Nigel Trudgill&lt;/p&gt;&lt;p&gt;Miss Katie Yeadon&lt;/p&gt;&lt;p&gt;Dr. Matthew Kurien&lt;/p&gt;&lt;p&gt;&lt;b&gt;Nigel Trudgill:&lt;/b&gt; Conceptualization; writing – original draft. &lt;b&gt;Katie Yeadon:&lt;/b&gt; Writing – review and editing. &lt;b&gt;Matthew Kurien:&lt;/b&gt; Writing – review and editing.&lt;/p&gt;&lt;p&gt;Not applicable.&lt;/p&gt;&lt;p&gt;Prof. Nigel Trudgill is a BSG Elected Councillor; Miss Katie Yeadon is the Chair of the ACPGBI Colo","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70404","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative detection of muscle retraction in colorectal ESD using computed tomography–colonography 直肠ESD术前肌肉回缩的ct -结肠镜检查。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-11 DOI: 10.1111/codi.70396
Shutaro Hike, Tetsuro Maruyama, Keisuke Matsusaka, Masaya Uesato, Toru Tochigi, Akira Nakano, Takahiro Arasawa, Shunsuke Kainuma, Takuya Hirosuna, Mayuko Kinoshita, Jun-ichiro Ikeda, Hisahiro Matsubara

Background

Muscle retraction (MR) is a major cause of technical difficulty and perforation during colorectal endoscopic sub-mucosal dissection (ESD). However, no established method exists for predicting MR preoperatively. This study investigated whether computed tomography–colonography (CTC) can detect MR before ESD.

Methods

We retrospectively analysed 69 patients who underwent colorectal ESD without muscular invasion (Validation 1). The serosal-side appearance of the tumour on CTC was classified into four types—bulge, matchstick, round depression and sharp depression—and compared with endoscopically observed MR (eMR). To validate the findings, 55 surgically resected colorectal cancers without muscular invasion were analysed for pathological MR (pMR) and correlated with the same CTC classification (Validation 2). Logistic regression analyses were performed to identify predictors of MR.

Results

In Validation 1, all eMR-positive lesions (5/5) showed the sharp depression type on CTC, whereas 3 of 64 eMR-negative lesions did (Fisher's exact test, p < 0.0001). In Validation 2, multivariate logistic regression showed that both the sharp depression type (OR 138, p < 0.0001) and severe sub-mucosal fibrosis (OR 4453, p = 0.0079) were independent predictors of pMR. Intero-bserver agreement was almost perfect (κ = 0.93–0.95).

Conclusions

The serosal-surface appearance of colorectal tumours on CTC, especially the sharp depression type, strongly predicts MR. CTC may serve as a simple, non-invasive preoperative tool for identifying MR and selecting optimal treatment strategies, including surgery, before colorectal ESD.

背景:在结肠内镜下粘膜下剥离术(ESD)中,肌肉回缩(MR)是技术困难和穿孔的主要原因。然而,术前预测MR的方法尚不成熟。本研究探讨了计算机断层扫描结肠镜(CTC)是否可以在ESD前检测MR。方法:回顾性分析69例未发生肌肉侵犯的结肠ESD患者(验证1)。将CTC上的血清侧肿瘤表现分为凸起型、火柴型、圆形凹陷型和尖锐凹陷型四种,并与内镜下观察的MR (eMR)进行比较。为了验证这一发现,我们分析了55例手术切除的无肌肉侵犯的结直肠癌的病理MR (pMR),并将其与相同的CTC分类相关联(验证2)。结果:在验证1中,所有emr阳性病变(5/5)在CTC上表现为急剧凹陷型,而64个emr阴性病变中有3个(Fisher精确检验,p)。结直肠肿瘤在CTC上的血清表面表现,特别是尖锐凹陷型,可以强烈预测MR。CTC可以作为一种简单、无创的术前工具,用于在结直肠ESD之前识别MR并选择最佳治疗策略,包括手术。
{"title":"Preoperative detection of muscle retraction in colorectal ESD using computed tomography–colonography","authors":"Shutaro Hike,&nbsp;Tetsuro Maruyama,&nbsp;Keisuke Matsusaka,&nbsp;Masaya Uesato,&nbsp;Toru Tochigi,&nbsp;Akira Nakano,&nbsp;Takahiro Arasawa,&nbsp;Shunsuke Kainuma,&nbsp;Takuya Hirosuna,&nbsp;Mayuko Kinoshita,&nbsp;Jun-ichiro Ikeda,&nbsp;Hisahiro Matsubara","doi":"10.1111/codi.70396","DOIUrl":"10.1111/codi.70396","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Muscle retraction (MR) is a major cause of technical difficulty and perforation during colorectal endoscopic sub-mucosal dissection (ESD). However, no established method exists for predicting MR preoperatively. This study investigated whether computed tomography–colonography (CTC) can detect MR before ESD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively analysed 69 patients who underwent colorectal ESD without muscular invasion (Validation 1). The serosal-side appearance of the tumour on CTC was classified into four types—bulge, matchstick, round depression and sharp depression—and compared with endoscopically observed MR (eMR). To validate the findings, 55 surgically resected colorectal cancers without muscular invasion were analysed for pathological MR (pMR) and correlated with the same CTC classification (Validation 2). Logistic regression analyses were performed to identify predictors of MR.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In Validation 1, all eMR-positive lesions (5/5) showed the sharp depression type on CTC, whereas 3 of 64 eMR-negative lesions did (Fisher's exact test, <i>p</i> &lt; 0.0001). In Validation 2, multivariate logistic regression showed that both the sharp depression type (OR 138, <i>p</i> &lt; 0.0001) and severe sub-mucosal fibrosis (OR 4453, <i>p</i> = 0.0079) were independent predictors of pMR. Intero-bserver agreement was almost perfect (<i>κ</i> = 0.93–0.95).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The serosal-surface appearance of colorectal tumours on CTC, especially the sharp depression type, strongly predicts MR. CTC may serve as a simple, non-invasive preoperative tool for identifying MR and selecting optimal treatment strategies, including surgery, before colorectal ESD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological profile of surgical treatment for colorectal cancer: Retrospective analysis of trends and regional disparities in Brazil, 2014–2024 结直肠癌手术治疗的流行病学概况:2014-2024年巴西趋势和地区差异的回顾性分析
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-10 DOI: 10.1111/codi.70387
Felipe Mendes Delpino, Francisco Tustumi, Marina Martins Siqueira, Gabriely Rangel Pereira, Marcelo Passos Teivelis, Lucas Hernandes Correa, Nelson Wolosker

Background

Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.

Methods

We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.

Results

In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.

Conclusion

Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.

背景:结直肠癌(CRC)由于其高发病率和死亡率,是巴西公共卫生面临的主要挑战。本研究考察了2014年至2024年间巴西CRC手术的时间趋势、地区差异和结果。方法:我们使用统一卫生系统医院信息系统(SIH-SUS)的数据进行回顾性观察分析。我们纳入了在此期间接受由SUS资助的结直肠癌手术的所有患者。我们分析了巴西五个地理区域的患者人口统计数据、每10万居民的手术率(不包括自愿私人健康保险覆盖的人口)、住院死亡率和住院时间。结果:我们共发现313531例结直肠癌手术。大多数患者年龄在60 - 69岁之间(30.1%),性别分布相似(男性50.2%)。各地区的手术率差别很大,从北方的每10万居民51.4例到南方的每10万居民319.9例。住院死亡率从5.2%到6.7%不等,因地理区域而异。在此期间,手术数量增加了74%,但2020年有所下降,这可能与COVID-19大流行有关。结论:我们的研究结果揭示了巴西公共卫生系统中CRC手术提供和住院结果的重大区域异质性,特别是影响北部地区。这些描述性模式可为卫生系统监测和未来面向政策的研究和决策提供信息。
{"title":"Epidemiological profile of surgical treatment for colorectal cancer: Retrospective analysis of trends and regional disparities in Brazil, 2014–2024","authors":"Felipe Mendes Delpino,&nbsp;Francisco Tustumi,&nbsp;Marina Martins Siqueira,&nbsp;Gabriely Rangel Pereira,&nbsp;Marcelo Passos Teivelis,&nbsp;Lucas Hernandes Correa,&nbsp;Nelson Wolosker","doi":"10.1111/codi.70387","DOIUrl":"10.1111/codi.70387","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Colorectal cancer (CRC) represents a major challenge for public health in Brazil due to its high incidence and mortality. This study examines temporal trends, regional disparities and outcomes of CRC surgeries performed in Brazil between 2014 and 2024.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a retrospective observational analysis using data from the Hospital Information System of the Unified Health System (SIH-SUS). We included all patients who underwent CRC surgery financed by the SUS during the period. We analysed patient demographics, surgery rates per 100,000 inhabitants (excluding the population covered by voluntary private health insurance), in-hospital mortality and length of stay in the five geographic regions of Brazil.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total, we identified 313,531 CRC surgeries. Most patients were between 60 and 69 years old (30.1%), with a similar distribution between genders (50.2% men). Surgery rates varied considerably across regions, from 51.4 per 100,000 inhabitants in the North to 319.9 in the South. In-hospital mortality ranged from 5.2% to 6.7%, with variation among geographic regions. The number of procedures increased by 74% during the period, except for a decline in 2020, possibly related to the COVID-19 pandemic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our findings reveal substantial regional heterogeneity in surgical provision and in-hospital outcomes for CRC within the Brazilian public health system, particularly affecting the North region. These descriptive patterns may inform health system monitoring and future policy-oriented research and decision making.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70387","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of intraoperative ICG fluorescence angiography to reduce anastomotic leak in left-sided colorectal resections: A systematic review and meta-analysis of RCTs 术中应用ICG荧光血管造影减少左侧结直肠切除术吻合口漏:随机对照试验的系统回顾和荟萃分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-10 DOI: 10.1111/codi.70378
Ahmed Boalot, JihDar Yau, Mahmudul Hasan, Xuanping Wang, Amira Younes, Madeline Hannah, Muneer Junejo

Aim

Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.

Methods

A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.

Results

Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53–0.73; I2 = 0%; prediction interval 0.50–0.77) and clinically significant leak (RR 0.66, 95% CI 0.51–0.85; I2 = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50–0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73–1.05).

Conclusion

Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.

目的:吻合口漏是左侧结直肠切除术后的一个严重并发症,具有很高的发病率、死亡率和医疗费用。本系统综述和荟萃分析评估术中吲哚菁绿(ICG)荧光血管造影是否能降低左侧结肠直肠癌切除术患者的吻合口漏率。方法:对主要数据库和试验注册库进行系统检索,比较ICG血管造影和标准视觉评估在成人择期左侧结肠直肠切除术中的应用。主要结局是总体和临床显著(ISGRC分级B/C)吻合口漏。风险比(rr)采用随机效应模型汇总。采用Cochrane ROB2工具评估偏倚风险。结果:纳入10项试验,涉及3772例患者。与对照组相比,ICG荧光血管造影减少了吻合口总漏(RR 0.62, 95% CI 0.53-0.73; I2 = 0%;预测区间0.50-0.77)和临床显著漏(RR 0.66, 95% CI 0.51-0.85; I2 = 0%)。假设基线泄漏率为10%,ICG可防止每27名患者发生一次泄漏。亚组分析显示,即使ICG没有提示手术计划修改,也有益处(RR 0.67, 95% CI 0.50-0.90)。在所有分析中,研究间异质性可以忽略不计。使用ICG没有延长手术时间,减少了术后并发症(RR 0.88, 95% CI 0.73-1.05)。结论:术中ICG荧光血管造影可显著降低左侧结直肠切除术后吻合口漏率,在不同手术环境下均有一致的益处。该技术实用,不延长作业时间。ICG血管造影在左侧结肠直肠切除术中是一种有价值的辅助手段。
{"title":"Use of intraoperative ICG fluorescence angiography to reduce anastomotic leak in left-sided colorectal resections: A systematic review and meta-analysis of RCTs","authors":"Ahmed Boalot,&nbsp;JihDar Yau,&nbsp;Mahmudul Hasan,&nbsp;Xuanping Wang,&nbsp;Amira Younes,&nbsp;Madeline Hannah,&nbsp;Muneer Junejo","doi":"10.1111/codi.70378","DOIUrl":"10.1111/codi.70378","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Anastomotic leak remains a serious complication after left-sided colorectal resection with substantial morbidity, mortality and healthcare costs. This systematic review and meta-analysis evaluated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces anastomotic leak rates in patients undergoing left-sided colorectal resections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A systematic search of major databases and trial registries was conducted for RCTs comparing ICG angiography with standard visual assessment in adults undergoing elective left-sided colorectal resection. The primary outcomes were overall and clinically significant (ISGRC Grade B/C) anastomotic leak. Risk ratios (RRs) were pooled using a random-effects model. Risk of bias was assessed with the Cochrane ROB2 tool.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Ten trials involving 3,772 patients were included. ICG fluorescence angiography, compared to control, reduced overall anastomotic leak (RR 0.62, 95% CI 0.53–0.73; <i>I</i><sup>2</sup> = 0%; prediction interval 0.50–0.77) and clinically significant leak (RR 0.66, 95% CI 0.51–0.85; <i>I</i><sup>2</sup> = 0%). Assuming a 10% baseline leak rate, ICG prevents one leak per 27 patients treated. Subgroup analysis showed benefit even when ICG did not prompt surgical plan modification (RR 0.67, 95% CI 0.50–0.90). Between-study heterogeneity was negligible across all analyses. ICG use did not prolong operating time and has reduced postoperative complications (RR 0.88, 95% CI 0.73–1.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Intraoperative ICG fluorescence angiography significantly reduces anastomotic leak rates after left-sided colorectal resection, with consistent benefit across diverse surgical settings. The technology is practical and does not prolong operating time. ICG angiography should be considered a valuable adjunct in left-sided colorectal resections.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"28 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1